Aberrant reprogramming of energy metabolism was frequently detected in many types of carcinomas including breast cancer, and CHES1 has been reported to modulate glucose homeostasis and insulin sensitivity in zebrafish and mouse models [24, 25, 43]. Here, FOXN3 is linked to breast carcinoma.